SCRIPPS RESEARCH INSTITUTE LA JOLLA, CA—The insomnia drug suvorexant (Belsomra®) might be an effective treatment for opioid use disorder, according to a preclinical study from Scripps Research. In the study, published April 27, 2023, in Frontiers in Pharmacology, the Scripps Research scientists found that suvorexant reduced prescription opioid intake and helped protect against relapse in rats modeling opioid use...